PDEI + 5‐ARI vs 5‐ARI alone
BPHII score
The review found no eligible studies for this question.
2 findings from 1 review
- Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
- Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found